2020-12-28 |
108 |
Order |
constructions for certain terms in U.S. Patent No. 9,572,887 (the “887 patent”),
and the Court held a Markman…2018
19 April 2022
1:18-cv-01074
835 Patent - Abbreviated New Drug Application(ANDA)
Plaintiff |
External link to document |
2022-04-20 |
160 |
Patent/Trademark Report to Commissioner of Patents |
Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,572,887 B2; US 10,010,533 B2; US 9,034,908…2018
19 April 2022
1:18-cv-01074
835 Patent - Abbreviated New Drug Application(ANDA)
Plaintiff |
External link to document |
2019-12-16 |
35 |
Memorandum Opinion |
1
U.S. Patent Nos. 10,010,533 (the "#533 patent"), 9,034,908 (the "#908 patent"),…quot;#568 patent"), 9,597,397 (the "#397 patent"), 9,597,398 (the
"#398 patent")…#399 patent"), 9,000,021 (the "#021 patent"), and
9,579,384 (the ·"#384 patent"… The ninth asserted patent, U.S. Patent No. 9,572,887 (the "#887 patent"),
requires a "…quot;).
to these patents as the "PG patents." In Counts II through IX and XI through
XVIII of |
External link to document |
2019-12-18 |
37 |
Memorandum Opinion |
1
U.S. Patent Nos. 10,010,533 (the "#533 patent"), 9,034,908 (the "#908 patent"),…quot;#568 patent"), 9,597,397 (the "#397 patent"), 9,597,398 (the
"#398 patent")…#399 patent"), 9,000,021 (the "#021 patent"), and
9,579,384 (the "#384 patent"… The ninth asserted patent, U.S. Patent No. 9,572,887 (the "#887 patent"),
requires a &…quot;).
to these patents as the "PG patents." In Counts II through IX and XI through
XVIII |
External link to document |